Bone Biologics Corporatio... (BBLGW)

AI Score

Unlock

20.20

4.60 (29.49%)

At close: Feb 26, 2025, 2:30 PM

Bone Biologics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-1.52M	-941K	-783.73K	-865.97K	-1.55M	-1.92M	-1.77M	-3.71M	893.46K	-1.22M	-469.3K	-689.5K	-177.74K	-509.3K	-491.9K	-431.75K	-453.71K	-394.05K	-380.03K	-596.9K	-531.15K	-561.42K	-925.55K	-1.41M	-1.47M	-241.75K	-1.26M	-1.45M	-2.31M	-2.53M	864.62K	-3.07M	-4.88M	-4.37M	-4.8M	-6.98M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.00	n/a	n/a	n/a	46.00	n/a	26.00	24.00	24.00	24.00	24.00	24.00	24.00	24.00	24.00	24.00	40.00	40.00	40.00	580.00
Stock-Based Compensation	100.75K	17.94K	17.44K	52.68K	71.14K	20.03K	16.67K	44.76K	62.51K	32.53K	18.75K	152.84K	207.03	n/a	n/a	15K	49.69K	n/a	n/a	15K	3.13K	7.29K	13.55K	25.72K	23.88K	101.16K	195.79K	195.79K	-1.99M	367.16K	530.47K	507.77K	521.25K	999.67K	1.01M	924.59K
Other Working Capital	-102.56K	382.74K	-204.48K	-315.74K	-556.12K	91.48K	-19.8K	-1.39M	-785.92K	62.63K	119.77K	-279.13K	-649.47K	347.14K	-404.1K	15K	145.56K	73.6K	53.58K	17.15K	1.15K	431.66K	-666.64K	47.63K	-613.81K	-128.75K	75.89K	48.77K	309.71K	396.51K	286.38K	47.2K	-225.91K	-89.76K	-29.89K	-1.63K
Other Non-Cash Items	-12.96K	9.97K	-10.79K	152.45K	-24.76K	-160.65K	-1.27M	562.92K	-2.18M	-696.3K	3.02K	197.84K	-102.77K	234.51K	260.02K	235.82K	247.28K	248.22K	247.32K	240.25K	253.55K	-352.07K	2.13K	1.49K	18.01K	28.68K	166.67K	166.67K	723.75K	1.1M	863.8K	681.98K	1.65M	318.35K	1.75M	285.44K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-60.05K	n/a	n/a	n/a	42.49K	n/a	26.46K	5.96K	5.11K	-1.04M	146.01K	171.89K	2.34M	105.56K	-3.37M	930.25K	1.47M	1.64M	35.25K	2.94M
Change in Working Capital	80.42K	340.93K	-118.79K	-452.81K	-514.51K	-494.89K	-609.9K	1.75M	-726.21K	791.46K	90.49K	-324.12K	78.65K	-47.98K	-404.1K	52.94K	80.74K	73.6K	53.58K	191.77K	-65.76K	431.66K	-666.64K	444.52K	84.92K	-128.75K	87.98K	101.39K	309.71K	396.51K	286.38K	-53.86K	-31.45K	-89.76K	-29.89K	295.57K
Operating Cash Flow	-1.35M	-572.16K	-895.87K	-1.3M	-2.02M	-2.56M	-3.63M	-1.35M	-1.95M	-395.28K	-360.06K	-860.78K	-186.85K	-277.77K	-635.98K	-127.98K	-125.69K	-72.23K	-79.13K	-149.88K	-297.69K	-474.54K	-1.55M	-928.97K	-1.34M	-1.28M	-666.84K	-818.88K	-931.7K	-561.03K	-829.32K	-1.01M	-1.27M	-1.51M	-2.03M	-2.53M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-504	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-504	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	276.71K	569.25K	199.15K	123.23K	74.69K	76.7K	128.16K	120K	500K	1M	700K	n/a	n/a	600K	n/a	n/a	700K	n/a	2M	1.2M	n/a	n/a	1.88M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.81M	299.00	n/a	n/a	n/a	n/a	n/a	4.43M	n/a	n/a	n/a	6.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.27M	n/a	n/a	n/a	700K	n/a	n/a	n/a	n/a	n/a	1.25M
Financial Cash Flow	1.11M	1.81M	299.00	1.5M	592K	n/a	4.45M	n/a	4.43M	n/a	n/a	n/a	6.86M	276.71K	569.25K	199.15K	123.23K	74.69K	76.7K	128.16K	120K	500K	1M	700K	-969.98K	3.27M	600K	500K	n/a	1.4M	n/a	2M	1.2M	n/a	n/a	5.63M
Net Cash Flow	-241.29K	1.23M	-895.57K	201.06K	-1.43M	-2.56M	819.49K	-1.35M	2.48M	-395.28K	-360.06K	-860.78K	6.67M	-1.06K	-66.73K	71.17K	21.68K	2.46K	-2.43K	-21.71K	-177.69K	25.46K	-550.03K	-228.97K	-1.34M	1.99M	-66.84K	-318.88K	-931.7K	838.97K	-829.32K	991.96K	-67.86K	-1.51M	-2.03M	3.11M
Free Cash Flow	-1.35M	-572.16K	-895.87K	-1.3M	-2.02M	-2.56M	-3.63M	-1.35M	-1.95M	-395.28K	-360.06K	-860.78K	-186.85K	-277.77K	-635.98K	-127.98K	-125.69K	-72.23K	-79.13K	-149.88K	-297.69K	-474.54K	-1.55M	-928.97K	-1.34M	-1.28M	-666.84K	-818.88K	-931.7K	-561.03K	-829.32K	-1.01M	-1.27M	-1.51M	-2.03M	-2.53M